Roivant Sciences Other Non-Current Liabilities decreased by 89.7% to $70.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 218.2%, from $22.00K to $70.00K. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -61.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.19M | $8.19M | $8.18M | $21.92M | $8.16M | $9.10M | $21.48M | $17.03M | $16.90M | $5.18M | $4.43M | $2.49M | $1.66M | $295.00K | $307.00K | $22.00K | $228.00K | $170.00K | $677.00K | $70.00K |
| QoQ Change | — | +0.0% | -0.2% | +168.1% | -62.8% | +11.6% | +135.9% | -20.7% | -0.8% | -69.4% | -14.4% | -43.7% | -33.4% | -82.2% | +4.1% | -92.8% | +936.4% | -25.4% | +298.2% | -89.7% |
| YoY Change | — | — | — | — | -0.4% | +11.2% | +162.7% | -22.3% | +107.1% | -43.2% | -79.4% | -85.4% | -90.2% | -94.3% | -93.1% | -99.1% | -86.3% | -42.4% | +120.5% | +218.2% |